SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 78 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $928,000 | +52.4% | 964,096 | +88.4% | 0.00% | – |
Q1 2022 | $609,000 | +102.3% | 511,824 | +454.5% | 0.00% | – |
Q4 2021 | $301,000 | -78.7% | 92,300 | -70.8% | 0.00% | -100.0% |
Q3 2021 | $1,414,000 | -53.5% | 316,375 | -43.3% | 0.00% | -50.0% |
Q2 2021 | $3,040,000 | +140.7% | 557,713 | +230.4% | 0.00% | +100.0% |
Q1 2021 | $1,263,000 | -69.4% | 168,793 | -55.6% | 0.00% | -66.7% |
Q4 2020 | $4,126,000 | +209.1% | 380,266 | +151.8% | 0.00% | +50.0% |
Q3 2020 | $1,335,000 | -18.2% | 151,026 | -1.3% | 0.00% | 0.0% |
Q2 2020 | $1,632,000 | -55.1% | 153,063 | -70.9% | 0.00% | -60.0% |
Q4 2019 | $3,632,000 | +1772.2% | 525,585 | +2699.4% | 0.01% | – |
Q3 2019 | $194,000 | -69.5% | 18,775 | -73.1% | 0.00% | -100.0% |
Q1 2019 | $637,000 | +18.8% | 69,715 | -27.5% | 0.00% | 0.0% |
Q4 2018 | $536,000 | -74.0% | 96,185 | -44.4% | 0.00% | -66.7% |
Q3 2018 | $2,059,000 | -46.3% | 172,846 | -54.0% | 0.00% | -40.0% |
Q2 2018 | $3,834,000 | +80.3% | 375,466 | +129.3% | 0.01% | +66.7% |
Q1 2018 | $2,126,000 | +27.6% | 163,770 | +44.7% | 0.00% | 0.0% |
Q3 2017 | $1,666,000 | +795.7% | 113,206 | +872.1% | 0.00% | – |
Q1 2017 | $186,000 | – | 11,646 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |